Kestra Medical Technologies Ltd (KMTS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... [Yahoo! Finance]
Kestra Medical Technologies, Ltd. (KMTS)
Company Research
Source: Yahoo! Finance
Gross Margin: 45.7% in Q1, up from 32.9% in the prior year period. Prescriptions: Over 4,200 prescriptions for the ASSURE system, a 51% increase year-over-year. Operating Expenses: $37.7 million in Q1, including $2.9 million of nonrecurring costs. Net Loss: $25.8 million in Q1, compared to $20.3 million in the prior year period. Adjusted EBITDA Loss: $19.4 million in Q1, compared to $15.7 million in the prior year period. Cash and Cash Equivalents: $201.2 million as of July 31, 2025. Fiscal Year 2026 Revenue Guidance: $88 million, a 47% increase compared to fiscal year 2025. Warning! GuruFocus has detected 1 Warning Sign with KMTS. Is KMTS fairly valued? Test your thesis with our free DCF calculator. Release Date: September 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Kestra Medical Technologies Ltd ( NASDAQ:KMTS ) reported a 52% year-over-year revenue growth to $19.4 million, driv
Show less
Read more
Impact Snapshot
Event Time:
KMTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMTS alerts
High impacting Kestra Medical Technologies, Ltd. news events
Weekly update
A roundup of the hottest topics
KMTS
News
- Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial ResultsGlobeNewswire
- Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common SharesGlobeNewswire
- Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common SharesGlobeNewswire
- Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial ResultsGlobeNewswire
- Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE DeviceGlobeNewswire
KMTS
Earnings
- 9/11/25 - Beat
KMTS
Sec Filings
- 12/4/25 - Form 4
- 12/4/25 - Form 8-K
- 12/3/25 - Form 424B4
- KMTS's page on the SEC website